EMBOSHIELD NAV6 EMBOLIC PROTECTION SYSTEM
Report
- Report Number
- 2024168-2011-04823
- Event Type
- Malfunction
- Date Received
- July 7, 2011
- Date of Event
- June 13, 2011
- Report Date
- June 13, 2011
- Manufacturer
- AV-TEMECULA-CT
- Product Code
- NTE
- PMA / PMN Number
- K090665
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THE DEVICE WAS RECEIVED. INVESTIGATION IS NOT YET COMPLETE. A FOLLOW UP REPORT WILL BE SUBMITTED WITH ALL ADDITIONAL RELEVANT INFORMATION.
(B)(4). EVALUATION SUMMARY: THE EMBOLIC PROTECTION SYSTEM (EPS) WAS RETURNED WITH BLOOD ON THE FILTRATION ELEMENT, RETRIEVAL CATHETER AND TORQUE DEVICE, CONSISTENT WITH THE REPORTED USE. THERE WAS NO SALINE VISIBLE. THE FILTRATION ELEMENT WAS FULLY DEPLOYED ON A NON-ABBOTT GUIDE WIRE. THE FILTRATION ELEMENT WIRE BROKE AT THE PROXIMAL MARKER BAND CONSISTENT WITH THE REPORTED INFORMATION. THERE WAS NO OTHER DAMAGE NOTED TO THE FILTRATION ELEMENT. THERE WAS NO OTHER DAMAGE NOTED TO THE EPS. THE NON-ABBOTT GUIDE WIRE WAS RETURNED WITH BLOOD ON THE CORE AND NO SALINE VISIBLE. THERE WAS NO DAMAGE NOTED TO THE GUIDE WIRE. PIN GAUGES WERE USED TO MEASURE THE INNER DIAMETER OF THE RETRIEVAL CATHETER, WHICH MET THE MANUFACTURING CRITERIA. DIFFICULTY RETRIEVING THE FILTRATION ELEMENT MAY INCLUDE, BUT IS NOT LIMITED TO, PATIENT ANATOMICAL CONDITIONS, STENT POST DILATATION STRATEGY, THE NEWLY DEPLOYED STENT NOT BEING FULLY APPOSED TO THE VESSEL WALL, LACK OF GUIDE CATHETER SUPPORT, INTERACTION BETWEEN ASSOCIATED DEVICES, DAMAGE TO THE RETRIEVAL CATHETER OR DAMAGE TO THE FILTRATION ELEMENT. IN THIS CASE, IT MAY BE POSSIBLE THAT ANATOMICAL CONDITIONS AND/OR USE OF THE EMBOSHIELD NAV 6 IN THE POPLITEAL ARTERY CAUSED OR CONTRIBUTED TO THE DIFFICULTY RETRIEVING. IT SHOULD BE NOTED THAT THE EMBOSHIELD NAV 6 INSTRUCTION FOR USE STATES: THE EMBOSHIELD NAV6 EMBOLIC PROTECTION SYSTEM IS INDICATED FOR USE AS A GUIDE WIRE AND EMBOLIC PROTECTION SYSTEM TO CONTAIN AND REMOVE EMBOLIC MATERIAL (THROMBUS / DEBRIS) WHILE PERFORMING ANGIOPLASTY AND STENTING PROCEDURES IN CAROTID ARTERIES. THE DIAMETER OF THE ARTERY AT THE SITE OF THE FILTRATION ELEMENT PLACEMENT SHOULD BE BETWEEN 2.5 AND 7.0 MM. IN THIS CASE, IT COULD NOT BE DETERMINED IF THE USE OF THE EMBOSHIELD NAV 6 IN THE POPLITEAL ARTERY CAUSED OR CONTRIBUTED TO THE DIFFICULTY. IT IS ALSO LIKELY THAT DURING THE ATTEMPTS TO PULL THE FILTER ASSEMBLY INTO THE RETRIEVAL CATHETER AGAINST FORCE CAUSED THE DAMAGE TO THE FILTRATION ELEMENT. A REVIEW OF THE FINISHED DEVICE LOT HISTORY RECORD DID NOT REVEAL ANY NONCONFORMING MATERIAL RECORDS FOR THIS LOT AND A QUERY OF THE DATABASE FOUND THERE HAVE BEEN NO OTHER INCIDENTS FOR DIFFICULT TO REMOVE OR BREAK REPORTED FOR THIS LOT. THE REPORTED DIFFICULTIES AND SUBSEQUENT DAMAGE APPEARS TO BE RELATED TO THE OPERATIONAL CONTEXT OF THE PROCEDURE. THERE IS NO INDICATION TO SUGGEST A PRODUCT QUALITY DEFICIENCY.
IT WAS REPORTED THAT THERE WAS DIFFICULTY REMOVING THE EMBOSHIELD NAV 6 EMBOLIC PROTECTION DEVICE (EPD) FROM THE POPLITEAL ARTERY. ON ANGIOGRAPHY THE RADIOPAQUE MARKERS DID NOT HAVE THE CORRECT SHAPE AND APPEARED TO BE STRETCHED OUT. THE EPD COULD ONLY BE PARTIALLY, HALF WAY ENCAPSULATED INTO RECOVERY CATHETER. THE GUIDE WIRE, RECOVERY CATHETER AND EPD WERE COMPLETELY REMOVED AS A SINGLE UNIT. AFTER REMOVAL, THE EPD WAS EXAMINED AND ONE RADIOPAQUE MARKER BAND WAS BROKEN AND WAS HANGING FROM THE PROXIMAL END. THERE WAS NO DEVICE SEPARATION. THERE WAS NO RESISTANCE FELT DURING ADVANCEMENT OR REMOVAL. THERE WAS NO ADVERSE PATIENT EFFECT OR CLINICALLY SIGNIFICANT DELAY IN PROCEDURE OR THERAPY. THOUGH REQUESTED NO ADDITIONAL INFORMATION WAS PROVIDED
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | EMBOSHIELD NAV6 EMBOLIC PROTECTION SYSTEM | EMBOLIC PROTECTION SYSTEM | NTE | AV-TEMECULA-CT | 1042051 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 63 YR |